Mark Cookson, PhD
Senior Investigator at National Institute on Aging, National Institutes of Health
Location: Bethesda, Maryland, United States
Dr. Mark R. Cookson is a cell biologist whose current research interests include the effects of mutations in the genes associated with neurodegeneration at the cellular and molecular level. His laboratory efforts are directed at finding the underlying pathways that lead to Parkinson's disease and related disorders. Dr. Cookson received both his BSc and PhD degrees from the University of Salford, UK in 1991 and 1995, respectively. His postdoctoral studies included time spent at the Medical Research Council laboratories and at the University of Newcastle, Newcastle, UK. He joined the Mayo Clinic, Jacksonville, Florida, as an Assistant Professor in 2000 and moved to the NIA in February 2002. Within the Laboratory of Neurogenetics, Dr. Cookson's group works on the effects of mutations associated with Parkinson's disease on protein function.
- Validation of Cyclin-G Associated kinase (GAK) as a Target for Parkinson's Disease (2016)
- Non-kinase Targets in LRRK2 Biology (2012)
- Biochemical characterization of full length human recombinant LRRK1 and LRRK2 (2010)
- Biochemical Characterization of Full Length Human Recombinant LRRK1 and LRRK2 (2009)